We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Expands Use of Remote Source Data Verification in Clinical Trials
EMA Expands Use of Remote Source Data Verification in Clinical Trials
The European Medicines Agency (EMA) has expanded the use and scope of remote source data verification (rSDV) in clinical trials as long as patients’ private data can be protected, according to a guidance update released this week.